Financings in Brief: Respironics:
This article was originally published in The Gray Sheet
Executive Summary
Respironics: Board of directors authorizes repurchase of up to 5% of company's common outstanding stock. Repurchases will be made "in the open market or through privately negotiated transactions," the firm says...